Oral Minoxidil Bio-Activation by Hair Follicle Outer Root Sheath Cell Sulfotransferase Enzymes Predicts Clinical Efficacy in Female Pattern Hair Loss

    Pablo Ramos, Amir Goren, Robert Sinclair, Hélio Amante Miot
    Image of study
    TLDR Minoxidil activation by hair enzymes predicts treatment success for female hair loss.
    The study investigated the bio-activation of oral minoxidil (OM) by hair follicle outer root sheath cell sulfotransferase enzymes and its clinical efficacy in treating female pattern hair loss (FPHL). The study found that ORS bio-activation predicts clinical response in the treatment of FPHL, and a lower follicular enzymatic activity threshold is required for bio-activation of OM compared to topical minoxidil. The study also developed a predictive biomarker for OM therapeutic response in FPHL. The results suggest that ORS sulfotransferase activity is a key factor in OM efficacy and could be used as a biomarker for predicting therapeutic response.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    8 / 8 results